查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1400997

按技术、治疗领域、最终用户、国家和地区分類的人类绒毛膜促性腺激素 (hCG) 市场与 COVID-19 影响分析 - 2023-2030 年行业分析、市场规模、市场份额和预测

Human Chorionic Gonadotropin (hCG) Market with COVID-19 Impact Analysis by Technology, Therapeutic Area, End User, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日期: | 出版商: AnalystView Market Insights | 英文 288 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2022 年人类绒毛膜促性腺激素 (hCG) 市场规模为 7,1,087 万美元，2023 年至 2030 年复合CAGR为 6.48%。

人类绒毛膜促性腺激素 (hCG) 市场-市场动态

不孕症和性腺功能减退症的盛行率不断上升，生活方式的改变以及对不孕症治疗的认识不断提高，以推动市场需求

不孕症和性腺功能减退症盛行率的上升、生活方式的改变以及不孕症治疗知识的提高都有助于人类绒毛膜促性腺激素 (HCG) 行业的扩张。例如，性腺功能减退症的定义是血清睪固酮激素浓度低，随后出现一系列临床特征，如晨勃不良、勃起功能障碍、记忆力减退、性慾低下、身体健康和体力下降、注意力不集中和忧郁。根据 BMC Endocrine Disorders 2021 年 7 月发布的研究，到 2021 年，勃起功能障碍将影响全球 72.2% 的成年人。

人类绒毛膜促性腺激素 (hCG) 市场 - 关键见解

根据我们的研究分析师分享的分析，全球人类绒毛膜促性腺激素 (hCG) 市场预计在预测期内（2023-2030 年）每年将以 6.48% 左右的CAGR增长

由于不孕症和性腺功能减退症盛行率的增加、生活方式的改变以及对不孕症治疗认识的提高，预计人类绒毛膜促性腺激素 (hCG) 行业将以显着的速度增长

基于技术细分，预计天然来源提取将在 2022 年显示最大的市场份额

基于治疗领域细分，2022年女性不孕症治疗技术领先

根据最终用户细分，生育诊所是 2022 年的领先技术

按地区划分，北美是 2022 年的主要收入来源

人类绒毛膜促性腺激素 (hCG) 市场-細項分析：

全球人类绒毛膜促性腺激素 (hCG) 市场根据技术、治疗领域、最终用户和地区进行细分。

市场根据产品技术分为两类：重组技术和天然来源提取。天然来源提取领域在全球市场中占据主导地位，并且在预测期内可能会继续如此。 hCG 领域的主要竞争对手对天然来源的促性腺激素有很高的需求，这是过去几年市场的重要发展，并为该领域的收入做出了重大贡献。

市场依治疗领域分为：男性性腺功能减退症、女性不孕症治疗、少精子症治疗等。不孕症被描述为夫妇无法怀孕或女性无法维持妊娠至足月。由于人类绒毛膜促性腺激素 (HCG) 激素对怀孕期间胚胎发育非常重要，因此其在不孕症治疗中的应用在男性和女性中都受到欢迎。女性不孕症可由多种因素引起。据世界卫生组织称，输卵管异常，如子宫疾病、输卵管阻塞、卵泡问题、多囊性卵巢症候群（PCOS）以及各种内分泌系统疾病是主要原因。

人类绒毛膜促性腺激素 (hCG) 市场 - 地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲地区。这些区域根据开展业务的国家进一步划分。在预测期内，北美预计将经历可观的市场成长。这一增长可能与该地区完善的医疗基础设施、有利的报销规定以及不断增加的不孕负担有关。

人类绒毛膜促性腺激素 (hCG) 市场-竞争格局：

公司透过多种管道销售产品，包括企业网站、电子商务网站、零售商、分销​​商和最终消费者。企业用来扩大影响力和扩大市场份额的一些主要技术包括新产品发布、分销网络开发、研发支出以及併购。例如，2022 年 6 月，Inception Fertility 推出了 HavenCryo，扩展了其生态系统，这是一种长期生物组织和冷冻保存解决方案，为生育专业人士和患者提供了独一无二的体验。

最近的发展：

2022 年 6 月，随着 HavenCryo 的推出，这是一种长期生殖组织和冷冻保存解决方案，为生育从业者和患者提供了独特的体验，Inception Fertility 扩展了其生态系统。

目录

第 1 章：人类绒毛膜促性腺激素 (hCG) 市场概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 按技术分類的人类绒毛膜促性腺激素 (hCG) 市场片段
    • 按治疗领域分類的人类绒毛膜促性腺激素 (hCG) 市场片段
    • 最终用户的人类绒毛膜促性腺激素 (hCG) 市场片段
    • 按国家/地区分類的人类绒毛膜促性腺激素 (hCG) 市场片段
    • 按地区分類的人类绒毛膜促性腺激素 (hCG) 市场片段
  • 竞争洞察

第 3 章：人类绒毛膜促性腺激素 (hCG) 主要市场趋势

  • 人类绒毛膜促性腺激素 (hCG) 市场驱动因素
    • 市场驱动因素的影响分析
  • 人类绒毛膜促性腺激素 (hCG) 市场限制
    • 市场限制影响分析
  • 人类绒毛膜促性腺激素 (hCG) 市场机会
  • 人类绒毛膜促性腺激素（hCG）市场未来趋势

第 4 章：人类绒毛膜促性腺激素 (hCG) 产业研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：人类绒毛膜促性腺激素 (hCG) 市场：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：人类绒毛膜促性腺激素 (hCG) 市场格局

  • 2022 年人类绒毛膜促性腺激素 (hCG) 市占分析
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：人类绒毛膜促性腺激素 (hCG) 市场 - 依技术

  • 概述
    • 按技术分類的细分市场份额分析
    • 重组技术
    • 天然来源萃取

第 8 章：人类绒毛膜促性腺激素 (hCG) 市场 - 依治疗领域

  • 概述
    • 按治疗领域分類的细分市场占有率分析
    • 男性性腺功能减退症
    • 女性不孕症治疗
    • 少精症治疗
    • 其他的

第 9 章：人类绒毛膜促性腺激素 (hCG) 市场 - 依最终用户

  • 概述
    • 按最终用户分類的细分市场占有率分析
    • 研究机构
    • 生育诊所
    • 其他的

第 10 章：人类绒毛膜促性腺激素 (hCG) 市场 - 依地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美人类绒毛膜促性腺激素 (hCG) 主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按技术）
    • 北美市场规模与预测（按治疗领域）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲人类绒毛膜促性腺激素 (hCG) 主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模与预测（按治疗领域）
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区人类绒毛膜促性腺激素 (hCG) 主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按技术）
    • 按治疗领域分類的亚太市场规模和预测
    • 亚太地区市场规模和预测（按最终用户）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 拉丁美洲人类绒毛膜促性腺激素 (hCG) 主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模与预测（按治疗领域）
    • 拉丁美洲市场规模和预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 中东和非洲人绒毛膜促性腺激素 (hCG) 主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按治疗领域）
    • 中东和非洲市场规模及预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第 11 章：主要供应商分析 - 人类绒毛膜促性腺激素 (hCG) 产业

  • 竞争仪表板
  • 公司简介
    • Zydus Cadila
    • Torrent Pharmaceuticals
    • Sun Pharmaceutical Industries Ltd.
    • Sigma-Aldrich (now part of MilliporeSigma)
    • Organon
    • Novartis
    • Merck
    • Mankind Pharma
    • Lupin Pharmaceuticals
    • Liqvor Pharmaceuticals
    • IBSA Pharma
    • Glenmark Pharmaceuticals
    • Ferring Pharmaceuticals
    • Bharat Serums and Vaccines Ltd.
    • Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV1961

REPORT HIGHLIGHT

Human Chorionic Gonadotropin (hCG) Market size was valued at USD 710.87 Million in 2022, expanding at a CAGR of 6.48% from 2023 to 2030.

Human Chorionic Gonadotropin (hCG) is a hormone generated by the placenta during pregnancy. It aids pregnancy by activating the corpus luteum in the ovaries to generate progesterone, which maintains the uterine lining and helps the growing fetus. hCG is also the hormone discovered in pregnancy tests since its levels grow considerably early in pregnancy. In addition to its role in reproduction, hCG has therapeutic applications, including as in fertility therapies and as a marker for various medical disorders, including several cancer technologies.

Human Chorionic Gonadotropin (hCG) Market- Market Dynamics

Increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment to propel market demand

The rising prevalence of infertility and hypogonadism, changing lifestyles, and improved knowledge about infertility therapy are all contributing to the expansion of the human chorionic gonadotropin (HCG) industry. Hypogonadism, for example, is defined by low serum the hormone testosterone concentration, which is followed by an array of clinical features such as poor morning erections, ED, memory loss, low libido, physical decline in health and power, difficulty concentrating, and depression. According to research published in July 2021 by BMC Endocrine Disorders, erectile dysfunction would affect 72.2% of adults worldwide in 2021.

Human Chorionic Gonadotropin (hCG) Market- Key Insights

As per the analysis shared by our research analyst, the global Human Chorionic Gonadotropin (hCG) market is estimated to grow annually at a CAGR of around 6.48% over the forecast period (2023-2030)

The Human Chorionic Gonadotropin (hCG) industry is projected to grow at a significant rate due to the increasing prevalence of infertility and hypogonadism, changing lifestyles, and increased awareness regarding infertility treatment

Based on Technology segmentation, natural source extraction was predicted to show maximum market share in the year 2022

Based on Therapeutic Area segmentation, Female Infertility Treatment was the leading Technology in 2022

Based on end user segmentation, Fertility Clinics was the leading Technology in 2022

On the basis of region, North America was the leading revenue generator in 2022

Human Chorionic Gonadotropin (hCG) Market- Segmentation Analysis:

The Global Human Chorionic Gonadotropin (hCG) Market is segmented on the basis of Technology, Therapeutic Area, End User, and Region.

The market is divided into categories based on product Technology: Recombinant Technology and Natural Source Extraction. The natural source extraction segment dominated the worldwide market and is likely to continue to do so during the forecast period. The leading competitors in the hCG sector have a high demand for gonadotropins derived from natural sources, which has been an important development in the market over the past few years and has contributed significantly to the income earned by this segment.

The market is divided into categories based on Therapeutic Area: Male Hypogonadism, Female Infertility Treatment, Oligospermia Treatment, and Others. Infertility is described as the couple's inability to become pregnant or the woman's inability to sustain a pregnancy to term. Because the human chorionic gonadotropin (HCG) hormone is important following embryo development during pregnancy, its usage in infertility therapy has gained popularity in both men and women. Female infertility can be caused by a variety of factors. Tubal abnormalities such as a uterine illness, blocked fallopian tube, follicular problems, polycystic ovarian syndrome (PCOS), various and endocrine system disorders are among the leading causes, according to the World Health Organization.

Human Chorionic Gonadotropin (hCG) Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business. Over the projection period, North America is expected to experience considerable market growth. The rise can be linked to the region's well-established healthcare infrastructure, advantageous reimbursement regulations, and the rising burden of infertility.

Human Chorionic Gonadotropin (hCG) Market- Competitive Landscape:

Companies sell their products through a variety of channels, including corporate websites, e-commerce websites, retailers, distributors, and end consumers. Some of the primary techniques used by corporations to strengthen their reach and expand their market share include new product launches, distribution network development, R&D spending, and mergers and acquisitions. For instance, in June 2022, Inception Fertility extended its ecosystem with the introduction of HavenCryo, a long-term biological tissue and cryopreservation preservation solution that provides fertility professionals and patients with a one-of-a-kind experience.

Recent Developments:

In June 2022, with the introduction of HavenCryo, a long-term reproductive tissue and cryopreservation storage solution that provides a distinctive experience for fertility practitioners and patients, Inception Fertility extended its ecosystem.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET KEY PLAYERS

  • Zydus Cadila
  • Torrent Pharmaceuticals
  • Sun Pharmaceutical Industries Ltd.
  • Sigma-Aldrich (now part of MilliporeSigma)
  • Organon
  • Novartis
  • Merck
  • Mankind Pharma
  • Lupin Pharmaceuticals
  • Liqvor Pharmaceuticals
  • IBSA Pharma
  • Glenmark Pharmaceuticals
  • Ferring Pharmaceuticals
  • Bharat Serums and Vaccines Ltd.
  • Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY TECHNOLOGY

  • Recombinant Technology
  • Natural Source Extraction

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY THERAPEUTIC AREA

  • Male Hypogonadism
  • Female Infertility Treatment
  • Oligospermia Treatment
  • Others

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY END USER

  • Research Institutes
  • Fertility Clinics
  • Others

GLOBAL HUMAN CHORIONIC GONADOTROPIN (HCG) MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Human Chorionic Gonadotropin (hCG) Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Human Chorionic Gonadotropin (hCG) Market Snippet by Technology
    • 2.1.2. Human Chorionic Gonadotropin (hCG) Market Snippet by Therapeutic Area
    • 2.1.3. Human Chorionic Gonadotropin (hCG) Market Snippet by End User
    • 2.1.4. Human Chorionic Gonadotropin (hCG) Market Snippet by Country
    • 2.1.5. Human Chorionic Gonadotropin (hCG) Market Snippet by Region
  • 2.2. Competitive Insights

3. Human Chorionic Gonadotropin (hCG) Key Market Trends

  • 3.1. Human Chorionic Gonadotropin (hCG) Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Human Chorionic Gonadotropin (hCG) Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Human Chorionic Gonadotropin (hCG) Market Opportunities
  • 3.4. Human Chorionic Gonadotropin (hCG) Market Future Trends

4. Human Chorionic Gonadotropin (hCG) Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Human Chorionic Gonadotropin (hCG) Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Human Chorionic Gonadotropin (hCG) Market Landscape

  • 6.1. Human Chorionic Gonadotropin (hCG) Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Human Chorionic Gonadotropin (hCG) Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2022 & 2030 (%)
    • 7.1.2. Recombinant Technology
    • 7.1.3. Natural Source Extraction

8. Human Chorionic Gonadotropin (hCG) Market - By Therapeutic Area

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Therapeutic Area, 2022 & 2030 (%)
    • 8.1.2. Male Hypogonadism
    • 8.1.3. Female Infertility Treatment
    • 8.1.4. Oligospermia Treatment
    • 8.1.5. Others

9. Human Chorionic Gonadotropin (hCG) Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2022 & 2030 (%)
    • 9.1.2. Research Institutes
    • 9.1.3. Fertility Clinics
    • 9.1.4. Others

10. Human Chorionic Gonadotropin (hCG) Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Human Chorionic Gonadotropin (hCG) Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Therapeutic Area, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Human Chorionic Gonadotropin (hCG) Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Zydus Cadila
    • 11.2.2. Torrent Pharmaceuticals
    • 11.2.3. Sun Pharmaceutical Industries Ltd.
    • 11.2.4. Sigma-Aldrich (now part of MilliporeSigma)
    • 11.2.5. Organon
    • 11.2.6. Novartis
    • 11.2.7. Merck
    • 11.2.8. Mankind Pharma
    • 11.2.9. Lupin Pharmaceuticals
    • 11.2.10. Liqvor Pharmaceuticals
    • 11.2.11. IBSA Pharma
    • 11.2.12. Glenmark Pharmaceuticals
    • 11.2.13. Ferring Pharmaceuticals
    • 11.2.14. Bharat Serums and Vaccines Ltd.
    • 11.2.15. Anhui Anke Biotechnology (Anhui Anke Biotechnology Co., Ltd.)

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Human Chorionic Gonadotropin (hCG) Market: Technology Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by Technology 2018-2030 (USD Million)
  • TABLE Human Chorionic Gonadotropin (hCG) Market: Therapeutic Area Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Area
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area 2018-2030 (USD Million)
  • TABLE Human Chorionic Gonadotropin (hCG) Market: End User Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by End User
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by End User 2018-2030 (USD Million)
  • TABLE Human Chorionic Gonadotropin (hCG) Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Human Chorionic Gonadotropin (hCG) Market, by Region 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE North America Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Europe Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Asia Pacific Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Latin America Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by Technology, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by Therapeutic Area, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Human Chorionic Gonadotropin (hCG) Market, by End User, 2018-2030 (USD Million)